| PVW Resources Limited (PVW) ORDINARY FULLY PAID |
Materials |
$6 |
Brazilian Rare Earths Portfolio Update
|
15 May 2025 8:23AM |
$0.012 |
$0.016 |
risen by
33.33%
|
|
PVW - Price-sensitive ASX Announcement
Full Release
Key Points
- PVW Resources Limited provided an update on its Brazilian Rare Earths Portfolio.
- The company has secured a significant landholding in Brazil, targeting ionic clay-hosted rare earth elements (REE) within the states of Minas Gerais and Bahia.
- PVW’s exploration approach is focused on identifying and developing high-grade rare earth mineralization in these ionic clays.
- Initial reconnaissance and sampling programs have confirmed the presence of rare earth elements, including high-value magnet rare earths such as neodymium and praseodymium.
- Several exploration licenses are in place and more are pending approval, covering more than 1,000 square kilometers.
- The company’s geological team is leveraging experience from established REE-producing regions, particularly in China and Brazil, to guide exploration activities.
- PVW is prioritizing areas with existing artisanal mining activity, favorable geology, and historical data indicating rare earth potential.
- The update highlights ongoing and planned activities, including drilling, systematic sampling, and metallurgical testing, to define resource potential and extraction viability.
- PVW is actively engaging with local communities and stakeholders to ensure responsible exploration practices.
- The company positions itself to benefit from increasing demand for rare earth elements driven by the global transition to renewable energy and electric vehicles.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Henderson Sustainable Credit Active ETF (Managed Fund) (GOOD) |
Financials |
$3 |
Monthly Factsheet - April 2025
|
15 May 2025 8:23AM |
$50.830 |
$50.470 |
fallen by
0.71%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$337 |
Update - Notification of buy-back - SVR
|
15 May 2025 8:23AM |
$1.715 |
$1.785 |
risen by
4.08%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$526 |
Update - Notification of buy-back - ACL
|
15 May 2025 8:23AM |
$3.040 |
$2.720 |
fallen by
10.53%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,915 |
Update - Notification of buy-back - DNL
|
15 May 2025 8:23AM |
$2.660 |
$3.310 |
risen by
24.44%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$987 |
Update - Notification of buy-back - PPM
|
15 May 2025 8:23AM |
$1.705 |
$2.220 |
risen by
30.21%
|
|
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$139 |
Update - Notification of buy-back - VLS
|
15 May 2025 8:23AM |
$1.850 |
$2.540 |
risen by
37.30%
|
|
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$3,486 |
Application for quotation of securities - SGM
|
15 May 2025 8:23AM |
$15.430 |
$18.040 |
risen by
16.92%
|
|
| WA1 Resources Ltd (WA1) ORDINARY FULLY PAID |
Materials |
$1,406 |
West Arunta Project - Luni Assay Results
|
15 May 2025 8:23AM |
$12.520 |
$18.930 |
risen by
51.20%
|
|
WA1 - Price-sensitive ASX Announcement
Full Release
Key Points
- WA1 Resources Ltd provides new assay results from Luni prospect, West Arunta Project.
- Significant high-grade niobium and rare earth element (REE) mineralisation confirmed.
- Drilling results show broad, continuous, and thick zones of mineralisation.
- Several drill holes returned standout intercepts, reinforcing the project's significance.
- Mineralised zones continue to expand with ongoing drilling and exploration work.
- The Luni prospect is highlighted as a major new discovery for niobium and REEs in Australia.
- WA1 Resources Ltd plans to continue drilling to further delineate mineralised zones.
- Project supports Australia's critical minerals strategy by focusing on niobium and REEs.
- The announcement underlines the company's leading position in critical mineral exploration.
- Assay results and geological work are ongoing and will be updated as further data is received.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$6,403 |
Update - Notification of buy-back - WOR
|
15 May 2025 8:23AM |
$13.250 |
$12.570 |
fallen by
5.13%
|
|
| Waypoint REIT Limited (WPR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,730 |
Update - Notification of buy-back - WPR
|
15 May 2025 8:23AM |
$2.590 |
$2.650 |
risen by
2.32%
|
|
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$1,594 |
First drilling in new area hits high-grade mineralisation
|
15 May 2025 8:22AM |
$0.900 |
$2.090 |
risen by
132.22%
|
|
FFM - Price-sensitive ASX Announcement
Full Release
Key Points
- FireFly Metals Ltd (FFM) has announced the results from the first drilling program in a previously untested area at its Green Bay Copper-Gold project in Newfoundland, Canada.
- Initial drilling has intersected significant high-grade copper and gold mineralisation, extending the known mineralised footprint of the project.
- The new area, named the ‘Northeast Extension’, returned notable intersections including 17.8m @ 4.5% Cu and 1.2g/t Au from 221.8m depth in hole GB24-101, among others.
- These results confirm the potential for further resource growth beyond the current deposit boundary.
- The drilling program remains ongoing with additional assays pending, aimed at testing further step-out targets and expanding the mineralised zones.
- The company highlights the technical expertise and systematic approach leading to these early exploration successes.
- FireFly Metals plans to accelerate exploration in the Green Bay project area to unlock more value for shareholders.
- Management emphasises the importance of the discovery for the overall resource potential and future development of the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lemvest Limited (LEV) ORDINARY FULLY PAID |
Industrials |
- |
Product Disclosure Statement
|
15 May 2025 8:22AM |
n/a |
n/a |
n/a
|
|
| Lemvest Limited (LEV) ORDINARY FULLY PAID |
Industrials |
- |
Admission and Commencement of Trading - LEVR
|
15 May 2025 8:22AM |
n/a |
n/a |
n/a
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$31,397 |
Update - Notification of buy-back - BXB
|
15 May 2025 8:22AM |
$21.500 |
$23.110 |
risen by
7.49%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$55,511 |
Statement of Changes in Beneficial Ownership
|
15 May 2025 8:22AM |
$90.250 |
$97.840 |
risen by
8.41%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$987 |
Proposed issue of securities - PPM
|
15 May 2025 8:22AM |
$1.705 |
$2.220 |
risen by
30.21%
|
|
| LendLease Group (LLC) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$3,495 |
Lendlease responds to media speculation
|
15 May 2025 8:22AM |
$5.480 |
$5.060 |
fallen by
7.66%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$987 |
Application for quotation of securities - PPM
|
15 May 2025 8:22AM |
$1.705 |
$2.220 |
risen by
30.21%
|
|
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,475 |
Update - Notification of buy-back - ABB
|
15 May 2025 8:22AM |
$4.000 |
$5.040 |
risen by
26%
|
|
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$119 |
Update - Notification of buy-back - SHJ
|
15 May 2025 8:21AM |
$0.700 |
$0.700 |
fallen by
0%
|
|
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,583 |
Appendix 3Y - Pauline Blight-Johnston
|
15 May 2025 8:21AM |
$5.280 |
$5.810 |
risen by
10.04%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$62 |
ACCENT Trial Achieves Superiority over Chemotherapy Alone
|
15 May 2025 8:21AM |
$0.055 |
$0.120 |
risen by
118.18%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- The ACCENT Phase 2 trial evaluated narmafotinib (AMP945) in combination with gemcitabine and nab-paclitaxel for advanced pancreatic cancer.
- The study achieved its primary endpoint, demonstrating superiority over chemotherapy alone in terms of Progression-Free Survival and Overall Survival.
- Interim analysis confirmed a statistically significant improvement in both PFS and OS compared to historical chemotherapy controls.
- Narmafotinib was well tolerated, with no meaningful increase in treatment-related adverse events.
- Amplia Therapeutics will engage with regulatory agencies to discuss these findings and plans to commence a Phase 3 registrational trial.
- Positive results support the potential of narmafotinib as a new treatment option for patients with advanced pancreatic cancer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$536 |
Update - Notification of buy-back - GEM
|
15 May 2025 8:21AM |
$1.295 |
$0.695 |
fallen by
46.33%
|
|
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,583 |
Notification regarding unquoted securities - HLI
|
15 May 2025 8:21AM |
$5.280 |
$5.810 |
risen by
10.04%
|
|